Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Sanofi, Regeneron's Dupixent could hit $20B in peak sales with COPD expansion: analyst
Fierce Pharma
Sun, 03/26/23 - 11:30 pm
Tags:
Sanofi, Regeneron, Dupixent, COPD
Sanofi and Regeneron's Dupixent scores trial win in tough-to-treat COPD
Fierce Pharma
Thu, 03/23/23 - 11:44 am
Tags:
Sanofi, Regeneron, Dupixent, COPD, clinical trials
FDA expands use of Regeneron's HoFH drug Evkeeza to kids 5 and up
Fierce Pharma
Wed, 03/22/23 - 11:14 am
Tags:
Regeneron, Evkeeza, pediatric, Homozygous Familial Hypercholesterolemia, FDA
AAD: Will Sanofi and Regeneron’s Dupixent be a game-changer or just another antibody on the COPD scrapheap?
Fierce Pharma
Mon, 03/20/23 - 10:06 am
Tags:
Sanofi, Regeneron, Dupixent, COPD
FDA Approves Regeneron-Sanofi's Sarilumab As First Biologic For Stiffness, Pain In Muscles
Yahoo/Benzinga
Wed, 03/1/23 - 07:07 pm
Tags:
Regeneron, Sanofi, FDA, Kevzara, Sarilumab, polymyalgia rheumatica
Go or no go? Vaccines and neurology up for discussion
EP Vantage
Tue, 02/28/23 - 11:05 am
Tags:
FDA, Acadia Pharmaceuticals, Apellis Pharmaceuticals, AstraZeneca, Biogen, Biomarin, Cidara Therapeutics, Emergent BioSolutions, GSK, Incyte, Ionis Pharmaceuticals, Melinta Therapeutics, Mundipharma, Novartis, Pfizer, Pharming, Regeneron, Roche, vaccines, RSV, ALS, COVID-19
Sanofi and Regeneron face a high-risk test for Dupixent
EP Vantage
Fri, 02/17/23 - 10:20 am
Tags:
Sanofi, Regeneron, Dupixent, COPD, clinical trials
US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case
Endpoints
Mon, 02/13/23 - 10:12 pm
Tags:
Pfizer, Viatris, Sanofi, Regeneron, patents, Supreme Court
In showdown with Roche, Regeneron gears up for potential Eylea expansion amid Covid decline
Endpoints
Mon, 02/6/23 - 10:35 am
Tags:
Regeneron, earnings, Eylea
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
Tags:
television ads, pharma marketing, DTC ads, AbbVie, Rinvoq, Dupixent, Sanofi, Regeneron, Skyrizi, Novo Nordisk, Ozempic, Jardiance, Eli Lilly, Boehringer Ingelheim, Rybelsus, Trulicity, Rexulti, Otsuka, Lundbeck, Tremfya, JNJ, Verzenio
In a win for Regeneron, Novartis' syringe for AMD drug declared 'unpatentable'
Endpoints
Thu, 01/26/23 - 05:05 pm
Tags:
Regeneron, Novartis, Eylea, drug delivery, patents, Lucentis
Coherus pays out $32M for exclusive US commercialization rights to Eylea biosimilar
Endpoints
Tue, 01/10/23 - 06:40 pm
Tags:
Coherus Biosciences, biosimilars, ophthalmology, Eylea, Regeneron
The Top New York Biopharma Companies Hiring Now
BioSpace
Mon, 01/9/23 - 10:58 pm
Tags:
New York, hirings, Regeneron, Lundbeck, Schrödinger
Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support
Endpoints
Tue, 01/3/23 - 10:24 pm
Tags:
Amgen, Sanofi, Regeneron, Supreme Court, legal, innovation, patents, Repatha, Praluent
10 clinical trials to watch in the first half of 2023
BioPharma Dive
Tue, 01/3/23 - 10:57 am
Tags:
clinical trials, Alzheimer's disease, obesity, Huntington's disease, M&A, AstraZeneca, Daiichi Sankyo, Nimbus Therapeutics, Takeda, Eli Lilly, Sanofi, Regeneron, Moderna Therapeutics, Gilead Sciences, Pfizer, Roivant, Alnylam, uniQure
Biotech’s key upcoming clinical results
EP Vantage
Tue, 12/20/22 - 10:27 am
Tags:
clinical trials, Acadia Pharmaceuticals, Argenx, Arrowhead Pharmaceuticals, Biomarin, BioNTech, Daiichi Sankyo, Day One, EQRx, Fate Therapeutics, FibroGen, Gilead Sciences, Idorsia, Immunogen, Intellia Therapeutics, Karuna Therapeutics, Moderna Therapeutics, Regeneron, Roche, Travere Therapeutics, Vaxcyte
ASH: Roche touts Lunsumio's durable efficacy as AbbVie, Regeneron plot lymphoma bispecific battle
Fierce Pharma
Mon, 12/12/22 - 10:21 am
Tags:
Roche, ASH 2022, AbbVie, Regeneron, lymphoma, Lunsumio, glofitamab
Regeneron's Yancopoulos draws boos as he touts pharma innovation over cost considerations
Fierce Biotech
Thu, 12/8/22 - 11:22 pm
Tags:
Regeneron, George Yancopoulos, innovation, Alzheimer's disease
Regeneron's Libtayo posts lung cancer win with Bristol's Yervoy. But company won't seek approval
Fierce Pharma
Thu, 12/1/22 - 07:11 pm
Tags:
Regeneron, Libtayo, non-small cell lung cancer, Bristol Myers Squibb, Yervoy
UK regulators warn of ocular side effects after treatment with Sanofi's Dupixent
Fierce Pharma
Thu, 12/1/22 - 10:43 am
Tags:
Regeneron, Sanofi, Dupixent, UK, side effects

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.